IMRA Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-12-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 296,550 | M-Exempt | D | 12,000 | 1.12 | 13,440.00 |
| 2023-12-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 12,000 | M-Exempt | A | 12,000 | 1.12 | 13,440.00 |
| 2023-12-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 2,849 | S-Sale | D | 9,151 | 14.13 | 129,268.00 |
| 2023-12-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 2,849 | 14.78 | 42,113.00 |
| 2023-12-28 | Patel Anish | officer: Chief Operating Officer | 33,117 | S-Sale | D | 2,520 | 15.08 | 37,996.00 |
| 2023-12-29 | Patel Anish | officer: Chief Operating Officer | 33,097 | S-Sale | D | 20 | 15.00 | 300.00 |
| 2024-01-02 | Patel Anish | officer: Chief Operating Officer | 22,097 | S-Sale | D | 11,000 | 15.00 | 165,053.00 |
| 2023-12-28 | Hohl Benjamin | officer: Chief Financial Officer | 258,523 | M-Exempt | D | 2,467 | 2.48 | 6,118.00 |
| 2023-12-29 | Hohl Benjamin | officer: Chief Financial Officer | 258,503 | M-Exempt | D | 20 | 2.48 | 49.60 |
| 2024-01-02 | Hohl Benjamin | officer: Chief Financial Officer | 249,120 | M-Exempt | D | 9,383 | 2.48 | 23,270.00 |
| 2024-01-02 | Hohl Benjamin | officer: Chief Financial Officer | 9,383 | M-Exempt | A | 9,383 | 2.48 | 23,270.00 |
| 2023-12-28 | Hohl Benjamin | officer: Chief Financial Officer | 2,467 | M-Exempt | A | 2,467 | 2.48 | 6,118.00 |
| 2023-12-29 | Hohl Benjamin | officer: Chief Financial Officer | 20 | M-Exempt | A | 20 | 2.48 | 49.60 |
| 2023-12-28 | Hohl Benjamin | officer: Chief Financial Officer | 0 | S-Sale | D | 2,467 | 15.07 | 37,188.00 |
| 2023-12-29 | Hohl Benjamin | officer: Chief Financial Officer | 0 | S-Sale | D | 20 | 15.00 | 300.00 |
| 2024-01-02 | Hohl Benjamin | officer: Chief Financial Officer | 0 | S-Sale | D | 9,383 | 15.01 | 140,839.00 |
| 2023-12-26 | Kintz Samuel | director, officer: President and CEO | 296,550 | M-Exempt | D | 12,000 | 1.12 | 13,440.00 |
| 2023-12-26 | Kintz Samuel | director, officer: President and CEO | 12,000 | M-Exempt | A | 12,000 | 1.12 | 13,440.00 |
| 2023-12-26 | Kintz Samuel | director, officer: President and CEO | 0 | S-Sale | D | 12,000 | 14.64 | 175,709.00 |
| 2023-12-22 | Patel Anish | officer: Chief Operating Officer | 35,739 | S-Sale | D | 983 | 15.03 | 14,776.00 |
| 2023-12-26 | Patel Anish | officer: Chief Operating Officer | 35,637 | S-Sale | D | 102 | 15.01 | 1,531.00 |
| 2023-12-22 | Hohl Benjamin | officer: Chief Financial Officer | 261,090 | M-Exempt | D | 1,030 | 2.48 | 2,554.00 |
| 2023-12-26 | Hohl Benjamin | officer: Chief Financial Officer | 260,990 | M-Exempt | D | 100 | 2.48 | 248.00 |
| 2023-12-22 | Hohl Benjamin | officer: Chief Financial Officer | 1,030 | M-Exempt | A | 1,030 | 2.48 | 2,554.00 |
| 2023-12-26 | Hohl Benjamin | officer: Chief Financial Officer | 100 | M-Exempt | A | 100 | 2.48 | 248.00 |
| 2023-12-26 | Hohl Benjamin | officer: Chief Financial Officer | 0 | S-Sale | D | 100 | 15.00 | 1,500.00 |
| 2023-12-22 | Hohl Benjamin | officer: Chief Financial Officer | 0 | S-Sale | D | 1,030 | 15.07 | 15,525.00 |
| 2023-12-21 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 315,096 | M-Exempt | D | 20 | 1.12 | 22.40 |
| 2023-12-22 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 308,550 | M-Exempt | D | 6,546 | 1.12 | 7,332.00 |
| 2023-12-22 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 6,546 | M-Exempt | A | 6,546 | 1.12 | 7,332.00 |
| 2023-12-21 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 20 | M-Exempt | A | 20 | 1.12 | 22.40 |
| 2023-12-22 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 6,546 | 13.07 | 85,530.00 |
| 2023-12-21 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 20 | 13.00 | 260.00 |
| 2023-12-21 | Kintz Samuel | director, officer: President and CEO | 316,725 | M-Exempt | D | 20 | 1.12 | 22.40 |
| 2023-12-22 | Kintz Samuel | director, officer: President and CEO | 308,550 | M-Exempt | D | 8,175 | 1.12 | 9,156.00 |
| 2023-12-22 | Kintz Samuel | director, officer: President and CEO | 8,175 | M-Exempt | A | 8,175 | 1.12 | 9,156.00 |
| 2023-12-21 | Kintz Samuel | director, officer: President and CEO | 20 | M-Exempt | A | 20 | 1.12 | 22.40 |
| 2023-12-22 | Kintz Samuel | director, officer: President and CEO | 0 | S-Sale | D | 8,175 | 13.05 | 106,655.00 |
| 2023-12-21 | Kintz Samuel | director, officer: President and CEO | 0 | S-Sale | D | 20 | 13.00 | 260.00 |
| 2023-12-21 | Heyman Richard A. | director | 147,448 | S-Sale | D | 7 | 13.00 | 91.00 |
| 2023-12-22 | Heyman Richard A. | director | 147,280 | S-Sale | D | 168 | 13.00 | 2,184.00 |
| 2023-12-21 | Heyman Richard A. | director | 29,251 | S-Sale | D | 6 | 13.00 | 78.00 |
| 2023-12-22 | Heyman Richard A. | director | 29,216 | S-Sale | D | 35 | 13.00 | 455.00 |
| 2023-12-20 | Kintz Samuel | director, officer: President and CEO | 316,745 | M-Exempt | D | 7,779 | 1.12 | 8,712.00 |
| 2023-12-20 | Kintz Samuel | director, officer: President and CEO | 7,779 | M-Exempt | A | 7,779 | 1.12 | 8,712.00 |
| 2023-12-20 | Kintz Samuel | director, officer: President and CEO | 0 | S-Sale | D | 7,779 | 13.01 | 101,238.00 |
| 2023-12-19 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 323,804 | M-Exempt | D | 200 | 1.12 | 224.00 |
| 2023-12-20 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 315,116 | M-Exempt | D | 8,688 | 1.12 | 9,731.00 |
| 2023-12-20 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 8,688 | M-Exempt | A | 8,688 | 1.12 | 9,731.00 |
| 2023-12-19 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 200 | M-Exempt | A | 200 | 1.12 | 224.00 |
| 2023-12-20 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 8,688 | 13.01 | 113,046.00 |
| 2023-12-19 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 200 | 13.00 | 2,600.00 |
| 2023-12-19 | Heyman Richard A. | director | 149,565 | S-Sale | D | 255 | 13.00 | 3,315.00 |
| 2023-12-20 | Heyman Richard A. | director | 147,455 | S-Sale | D | 2,110 | 13.02 | 27,473.00 |
| 2023-12-20 | Heyman Richard A. | director | 29,257 | S-Sale | D | 1,915 | 13.02 | 24,939.00 |
| 2023-11-03 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 324,004 | M-Exempt | D | 8,546 | 1.12 | 9,572.00 |
| 2023-11-03 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 8,546 | M-Exempt | A | 8,546 | 1.12 | 9,572.00 |
| 2023-11-03 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 8,546 | 13.08 | 111,751.00 |
| 2023-11-03 | Kintz Samuel | director, officer: President and CEO | 324,524 | M-Exempt | D | 8,026 | 1.12 | 8,989.00 |
| 2023-11-03 | Kintz Samuel | director, officer: President and CEO | 8,026 | M-Exempt | A | 8,026 | 1.12 | 8,989.00 |
| 2023-11-03 | Kintz Samuel | director, officer: President and CEO | 0 | S-Sale | D | 8,026 | 13.08 | 104,999.00 |
| 2023-09-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 332,550 | M-Exempt | D | 12,000 | 1.12 | 13,440.00 |
| 2023-09-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 12,000 | M-Exempt | A | 12,000 | 1.12 | 13,440.00 |
| 2023-09-29 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 0 | S-Sale | D | 12,000 | 13.62 | 163,498.00 |
| 2023-09-26 | 5AM Partners VI, LLC | 10 percent owner | 4,306,179 | S-Sale | D | 164,789 | 15.00 | 2,471,835.00 |
| 2023-09-26 | 5AM Partners VI, LLC | 10 percent owner | 854,796 | S-Sale | D | 32,711 | 15.00 | 490,665.00 |
| 2023-09-25 | Kintz Samuel | director, officer: President and CEO | 332,550 | M-Exempt | D | 12,000 | 1.12 | 13,440.00 |
| 2023-09-25 | Kintz Samuel | director, officer: President and CEO | 12,000 | M-Exempt | A | 12,000 | 1.12 | 13,440.00 |
| 2023-09-25 | Kintz Samuel | director, officer: President and CEO | 0 | S-Sale | D | 12,000 | 13.81 | 165,691.00 |
| 2023-08-24 | 5AM Partners VI, LLC | 10 percent owner | 4,470,968 | S-Sale | D | 367,124 | 16.00 | 5,873,984.00 |
| 2023-08-24 | 5AM Partners VI, LLC | 10 percent owner | 887,507 | S-Sale | D | 72,876 | 16.00 | 1,166,016.00 |
| 2023-05-17 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 8,663,349 | M-Exempt | A | 2,125 | 4.28 | 9,095.00 |
| 2023-05-17 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 0 | M-Exempt | D | 2,125 | 4.28 | 9,095.00 |
| 2023-05-17 | Gupta Rishi | director, 10 percent owner: | 8,663,349 | M-Exempt | A | 2,125 | 4.28 | 9,095.00 |
| 2023-05-17 | Gupta Rishi | director, 10 percent owner: | 0 | M-Exempt | D | 2,125 | 4.28 | 9,095.00 |
| 2023-04-04 | Patel Anish | officer: Chief Operating Officer | 206,000 | A-Award | A | 206,000 | 22.75 | 4,686,500.00 |
| 2023-04-04 | Lyssikatos Joseph P | director, officer: Chief Scientific Officer | 206,000 | A-Award | A | 206,000 | 22.75 | 4,686,500.00 |
| 2023-04-04 | Hohl Benjamin | officer: Chief Financial Officer | 206,000 | A-Award | A | 206,000 | 22.75 | 4,686,500.00 |
| 2023-04-04 | Collins Helen Louise | officer: Chief Medical Officer | 206,000 | A-Award | A | 206,000 | 22.75 | 4,686,500.00 |
| 2023-04-04 | Kintz Samuel | director, officer: President and CEO | 452,000 | A-Award | A | 452,000 | 22.75 | 10,283,000.00 |
| 2023-02-23 | Schwab Andrew J. | director, 10 percent owner: | 27,567 | A-Award | A | 27,567 | 25.28 | 696,894.00 |
| 2023-02-23 | Phillips Andrew John | director | 27,567 | A-Award | A | 27,567 | 25.28 | 696,894.00 |
| 2023-02-23 | Heyman Richard A. | director | 34,458 | A-Award | A | 34,458 | 25.28 | 871,098.00 |
| 2023-02-23 | Gupta Rishi | director, 10 percent owner: | 27,567 | A-Award | A | 27,567 | 25.28 | 696,894.00 |
| 2023-02-23 | Derynck Mika K | director | 27,567 | A-Award | A | 27,567 | 25.28 | 696,894.00 |
| 2023-02-23 | Bauer Jake | director | 27,567 | A-Award | A | 27,567 | 25.28 | 696,894.00 |
| 2023-02-23 | Ballal Rahul D. | director | 27,567 | A-Award | A | 27,567 | 25.28 | 696,894.00 |
| 2023-02-23 | 5AM Partners VI, LLC | 10 percent owner | 4,838,092 | I | 0 | 0.00 | 0.00 | |
| 2023-02-23 | 5AM Partners VI, LLC | 10 percent owner | 960,383 | I | 0 | 0.00 | 0.00 | |
| 2023-02-23 | Schwab Andrew J. | director | 4,838,092 | A-Award | A | 4,838,092 | 0.00 | 0.00 |
| 2023-02-23 | Schwab Andrew J. | director | 960,383 | A-Award | A | 960,383 | 0.00 | 0.00 |
| 2023-02-23 | Heyman Richard A. | director | 149,820 | A-Award | A | 149,820 | 0.00 | 0.00 |
| 2023-02-23 | Heyman Richard A. | director | 37,407 | A-Award | A | 37,407 | 0.00 | 0.00 |
| 2023-02-23 | Heyman Richard A. | director | 31,172 | A-Award | A | 31,172 | 0.00 | 0.00 |
| 2023-02-23 | Heyman Richard A. | director | 20,657 | A-Award | A | 20,657 | 2.48 | 51,229.00 |
| 2023-02-23 | Heyman Richard A. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-02-23 | Gupta Rishi | director, 10 percent owner: | 7,611,458 | A-Award | A | 7,611,458 | 0.00 | 0.00 |
| 2023-02-23 | Gupta Rishi | director, 10 percent owner: | 288,114 | A-Award | A | 288,114 | 0.00 | 0.00 |
| 2023-02-23 | Bauer Jake | director | 87,372 | A-Award | A | 87,372 | 0.00 | 0.00 |
| 2023-02-23 | Bauer Jake | director | 17,706 | A-Award | A | 17,706 | 2.48 | 43,911.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
